330 related articles for article (PubMed ID: 12445034)
1. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
[TBL] [Abstract][Full Text] [Related]
2. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
3. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
[TBL] [Abstract][Full Text] [Related]
4. [Cream PUVA photochemotherapy].
Stege H; Berneburg M; Ruzicka T; Krutmann J
Hautarzt; 1997 Feb; 48(2):89-93. PubMed ID: 9173066
[TBL] [Abstract][Full Text] [Related]
5. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath.
Schempp CM; Schöpf E; Simon JC
Photodermatol Photoimmunol Photomed; 1996 Jun; 12(3):100-2. PubMed ID: 8956358
[TBL] [Abstract][Full Text] [Related]
6. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
7. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
[TBL] [Abstract][Full Text] [Related]
8. Permeation characteristics of 8-methoxypsoralen through human skin; relevance to clinical treatment.
Anigbogu AN; Williams AC; Barry BW
J Pharm Pharmacol; 1996 Apr; 48(4):357-66. PubMed ID: 8794983
[TBL] [Abstract][Full Text] [Related]
9. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA.
Hannuksela-Svahn A; Pukkala E; Koulu L; Jansén CT; Karvonen J
J Am Acad Dermatol; 1999 May; 40(5 Pt 1):694-6. PubMed ID: 10321595
[TBL] [Abstract][Full Text] [Related]
10. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
Saïd A; Makki S; Muret P; Humbert P; Millet J
J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy.
Shephard SE; Panizzon RG
Dermatology; 1999; 199(2):106-12. PubMed ID: 10559574
[TBL] [Abstract][Full Text] [Related]
12. Penetration kinetics of 8-methoxypsoralen after 8-methoxypsoralen bath procedure with and without UVA irradiation.
Neumann NJ; Grosse OJ; Ruzicka T; Lehmann P
Skin Pharmacol Appl Skin Physiol; 2001; 14(4):210-6. PubMed ID: 11464103
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
[TBL] [Abstract][Full Text] [Related]
14. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy.
Grundmann-Kollmann M; Behrens S; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):87-9. PubMed ID: 10321522
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of 8-methoxypsoralen after topical paint PUVA.
Pham CT; Koo JY
J Am Acad Dermatol; 1993 Mar; 28(3):460-6. PubMed ID: 8445063
[TBL] [Abstract][Full Text] [Related]
17. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles.
Behrens S; von Kobyletzki G; Gruss C; Reuther T; Altmeyer P; Kerscher M
Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):47-51. PubMed ID: 10321515
[TBL] [Abstract][Full Text] [Related]
18. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 8-MOP aqueous bath and 8-MOP ethanolic lotion (Meladinine) in local PUVA therapy.
Shephard SE; Schregenberger N; Dummer R; Panizzon RG
Dermatology; 1998; 197(1):25-30. PubMed ID: 9693181
[TBL] [Abstract][Full Text] [Related]
20. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]